Literature DB >> 29955202

Addiction medicine and addiction psychiatry in America: Commonalities in the medical treatment of addiction.

Christopher R Freed.   

Abstract

Two competing medical disciplines treat addiction in the United States: addiction medicine and addiction psychiatry. Addiction medicine seeks recognition from the American Board of Medical Specialties whereas addiction psychiatry holds this high-level medical status, a mission that suggests a substantive distinction between addiction medicine physicians and addiction psychiatrists that does not exist. As this article shows, leading addiction medicine physicians and addiction psychiatrists agree on the definition of addiction and that drug treatment is an "art" which requires a multimethod approach. Despite this extensive accord, addiction medicine physicians and addiction psychiatrists draw sharp distinctions between addiction medicine and addiction psychiatry to serve historical, economic, and professional interests, revealing the importance to both disciplines of recognition from the American Board of Medical Specialties and thus jurisdiction over the medical treatment of addiction.

Entities:  

Keywords:  United States; addiction treatment; jurisdiction; medical recognition; medicine; psychiatry

Year:  2010        PMID: 29955202      PMCID: PMC6019277          DOI: 10.1177/009145091003700107

Source DB:  PubMed          Journal:  Contemp Drug Probl        ISSN: 0091-4509


  15 in total

1.  Addiction becomes a brain disease.

Authors:  R A Wise
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Alcoholism and the medical profession.

Authors:  M BLOCK
Journal:  J Ark Med Soc       Date:  1959-04

3.  The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism.

Authors:  R M Morse; D K Flavin
Journal:  JAMA       Date:  1992-08-26       Impact factor: 56.272

Review 4.  Telephone interviewing in healthcare research: a summary of the evidence.

Authors:  Elizabeth M Smith
Journal:  Nurse Res       Date:  2005

5.  What's in a word? Addiction versus dependence in DSM-V.

Authors:  Charles P O'Brien; Nora Volkow; T-K Li
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

6.  Future funding for mental health and substance abuse: increasing burdens for the public sector.

Authors:  Katharine R Levit; Cheryl A Kassed; Rosanna M Coffey; Tami L Mark; Elizabeth M Stranges; Jeffrey A Buck; Rita Vandivort-Warren
Journal:  Health Aff (Millwood)       Date:  2008-10-07       Impact factor: 6.301

7.  Physician impairment: past, present, future.

Authors:  E M Steindler
Journal:  J Med Assoc Ga       Date:  1984-11

8.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

9.  Costs and utilization of substance abuse care in a privately insured population under managed care.

Authors:  M Schoenbaum; W Zhang; R Sturm
Journal:  Psychiatr Serv       Date:  1998-12       Impact factor: 3.084

Review 10.  Substance abuse disorders: a psychiatric priority. Group for the Advancement of Psychiatry Committee on Alcoholism and the Addictions.

Authors: 
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

View more
  1 in total

1.  Been There, Done That: Lessons from Vancouver's Efforts to Stem the Tide of Overdose Deaths.

Authors:  Michael R Krausz; James S H Wong; Ehsan Moazen-Zadeh; Kerry L Jang
Journal:  Can J Psychiatry       Date:  2020-03-16       Impact factor: 4.356

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.